Ivabradine Versus Propranolol for Induced Hypotension in Endoscopic Sinus Surgery
NCT ID: NCT04580342
Last Updated: 2020-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
60 participants
INTERVENTIONAL
2020-10-15
2021-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Ivabradine Versus Propranolol Premedication During Hypotensive Anesthesia in Endoscopic Sinus Surgery
NCT04208594
Effects of Nitroglycerin Versus Labetalol on Tissue Perfusion During Deliberate Hypotension
NCT03809065
Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries
NCT04914234
Efficacy of Oral Verapamil and Oral Diltiazim on Reduction of Intraoperative Bleeding During Endoscopic Sinus Surgery Under General Anesthesia
NCT04790331
Is Labetalol More Effective Than Metoprolol for Controlled Hypotensive Anesthesia During Endoscopic Nasal Surgeries?
NCT05368376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ivabradine group
oral Ivabradine
Ivabradine group will receive ivabradine 5mg PO in the evening and 1 hour before anesthetic induction
propranolol group
oral Propranolol
propranolol group will receive propranolol 10 mg PO in the evening and 1 hour before anesthetic induction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral Ivabradine
Ivabradine group will receive ivabradine 5mg PO in the evening and 1 hour before anesthetic induction
oral Propranolol
propranolol group will receive propranolol 10 mg PO in the evening and 1 hour before anesthetic induction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients of both genders.
* ASA grade I - II .
Exclusion Criteria
* Any contraindication to medication included in the study .
* Patients with allergy to medication included in the study.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahmed talaat ahmed aly
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed talaat ahmed aly
clinical professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed T Ahmed, A professor
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Talaat Ahmed
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ivabradine versus propranolol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.